“This lens represents an important step forward for our patients,” said Dr. Steven J. Dell. “The TECNIS PureSee™ IOL offers something genuinely new: a premium extended depth of focus lens that doesn’t ...
The Vision business at Johnson & Johnson MedTech has hit its latest milestone, earning a significant regulatory nod for its ...
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Johnson & Johnson (NYSE:JNJ) received FDA approval for its ...
Please provide your email address to receive an email when new articles are posted on . The VirtIOL device may be an effective tool to measure the visual performance of IOLs before implantation. The ...
Please provide your email address to receive an email when new articles are posted on . Significantly more patients with multifocal IOLs were spectacle-free for near tasks than those with monofocal ...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
Monocular contrast sensitivity and microperimetry are useful indicators of visual function and its impact on activities of daily living in those with AMD. Patients with AMD do not rely on binocular ...
GENEVA--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have been ...